My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    FADD adaptor in cancer.

    Tourneur L, Buzyn A, Chiocchia G.

    Med Immunol. 2005 Feb 17;4(1):1.PMID: 15717929 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects.

    Osborn SL, Sohn SJ, Winoto A.

    J Biol Chem. 2007 Aug 3;282(31):22786-92. Epub 2007 Jun 6.PMID: 17553783 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adenosine receptors control a new pathway of Fas-associated death domain protein expression regulation by secretion.

    Tourneur L, Mistou S, Schmitt A, Chiocchia G.

    J Biol Chem. 2008 Jun 27;283(26):17929-38. Epub 2008 Apr 29.PMID: 18445587 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation.

    Werner MH, Wu C, Walsh CM.

    Cell Cycle. 2006 Oct;5(20):2332-8. Epub 2006 Oct 16. Review.PMID: 17102623 [PubMed - indexed for MEDLINE]Related articles

    5.

    The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation.

    Imtiyaz HZ, Zhou X, Zhang H, Chen D, Hu T, Zhang J.

    J Biol Chem. 2009 Apr 10;284(15):9917-26. Epub 2009 Feb 9.PMID: 19203997 [PubMed - indexed for MEDLINE]Related articles

    6.

    Protein kinase Cepsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis.

    Aziz MH, Sundling KE, Dreckschmidt NE, Verma AK.

    J Invest Dermatol. 2009 Aug;129(8):2011-21. Epub 2009 Feb 5.PMID: 19194472 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer.

    Bhojani MS, Chen G, Ross BD, Beer DG, Rehemtulla A.

    Cell Cycle. 2005 Nov;4(11):1478-81. Epub 2005 Nov 20. Review.PMID: 16258269 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression.

    Shimada K, Matsuyoshi S, Nakamura M, Ishida E, Konishi N.

    J Pathol. 2005 Aug;206(4):423-32.PMID: 15906275 [PubMed - indexed for MEDLINE]Related articles

    9.

    FADD phosphorylation is critical for cell cycle regulation in breast cancer cells.

    Matsuyoshi S, Shimada K, Nakamura M, Ishida E, Konishi N.

    Br J Cancer. 2006 Feb 27;94(4):532-9.PMID: 16450001 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Fas-associated death-domain protein inhibits TNF-alpha mediated NF-kappaB activation in cardiomyocytes.

    Chao W, Shen Y, Li L, Zhao H, Meiler SE, Cook SA, Rosenzweig A.

    Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2073-80. Epub 2005 Jun 24.PMID: 15980038 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes.

    Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A, Coutant A, Baffet G, Peter ME, Fardel O, Guguen-Guillouzo C.

    Carcinogenesis. 2005 Dec;26(12):2086-94. Epub 2005 Jul 20.PMID: 16033771 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.

    Chen G, Bhojani MS, Heaford AC, Chang DC, Laxman B, Thomas DG, Griffin LB, Yu J, Coppola JM, Giordano TJ, Lin L, Adams D, Orringer MB, Ross BD, Beer DG, Rehemtulla A.

    Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12507-12. Epub 2005 Aug 18.PMID: 16109772 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice.

    Allison J, Thomas HE, Catterall T, Kay TW, Strasser A.

    J Immunol. 2005 Jul 1;175(1):293-301.PMID: 15972661 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Lethal activity of FADD death domain in renal tubular epithelial cells.

    Justo P, Sanz AB, Lorz C, Egido J, Ortiz A.

    Kidney Int. 2006 Jun;69(12):2205-11. Epub 2006 May 3.PMID: 16688118 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a delta-opioid tone inhibits FADD.

    García-Fuster MJ, Ferrer-Alcón M, Martín M, Kieffer BL, Maldonado R, García-Sevilla JA.

    Eur Neuropsychopharmacol. 2007 Apr;17(5):366-74. Epub 2006 Oct 9.PMID: 17030115 [PubMed - indexed for MEDLINE]Related articles

    16.

    Structural requirements for signal-induced target binding of FADD determined by functional reconstitution of FADD deficiency.

    Imtiyaz HZ, Zhang Y, Zhang J.

    J Biol Chem. 2005 Sep 9;280(36):31360-7. Epub 2005 Jul 11.PMID: 16009710 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Structure of the Fas/FADD complex: a conditional death domain complex mediating signaling by receptor clustering.

    Salvesen GS, Riedl SJ.

    Cell Cycle. 2009 Sep 1;8(17):2723-7. Epub 2009 Sep 30.PMID: 19652545 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.

    Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA.

    Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3265-71.PMID: 16740746 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Phosphorylation status of fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cancer outcomes.

    Matsumura Y, Shimada K, Tanaka N, Fujimoto K, Hirao Y, Konishi N.

    Pathobiology. 2009;76(6):293-302. Epub 2009 Nov 30.PMID: 19955841 [PubMed - indexed for MEDLINE]Related articles

    20.

    Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis.

    Matsuda N, Yamamoto S, Takano K, Kageyama S, Kurobe Y, Yoshihara Y, Takano Y, Hattori Y.

    Am J Respir Crit Care Med. 2009 May 1;179(9):806-15. Epub 2009 Feb 6.PMID: 19201926 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk